90 related articles for article (PubMed ID: 20638623)
1. Endovascular intervention for treatment of claudication: is it cost-effective?
O'Brien-Irr MS; Harris LM; Dosluoglu HH; Dryjski ML
Ann Vasc Surg; 2010 Aug; 24(6):833-40. PubMed ID: 20638623
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of endovascular revascularization compared to supervised hospital-based exercise training in patients with intermittent claudication: a randomized controlled trial.
Spronk S; Bosch JL; den Hoed PT; Veen HF; Pattynama PM; Hunink MG
J Vasc Surg; 2008 Dec; 48(6):1472-80. PubMed ID: 18771879
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of supervised exercise, stenting, and optimal medical care for claudication: results from the Claudication: Exercise Versus Endoluminal Revascularization (CLEVER) trial.
Reynolds MR; Apruzzese P; Galper BZ; Murphy TP; Hirsch AT; Cutlip DE; Mohler ER; Regensteiner JG; Cohen DJ
J Am Heart Assoc; 2014 Nov; 3(6):e001233. PubMed ID: 25389284
[TBL] [Abstract][Full Text] [Related]
4. Clinical outcomes and medical care costs among medicare beneficiaries receiving therapy for peripheral arterial disease.
Jaff MR; Cahill KE; Yu AP; Birnbaum HG; Engelhart LM
Ann Vasc Surg; 2010 Jul; 24(5):577-87. PubMed ID: 20579582
[TBL] [Abstract][Full Text] [Related]
5. One-year clinical results and total costs of drug-eluting stents implantation in multivessel coronary artery disease.
Varani E; Balducelli M; Vecchi G; Aquilina M; Maresta A
J Cardiovasc Med (Hagerstown); 2007 Aug; 8(8):596-601. PubMed ID: 17667030
[TBL] [Abstract][Full Text] [Related]
6. Intermittent claudication: cost-effectiveness of revascularization versus exercise therapy.
de Vries SO; Visser K; de Vries JA; Wong JB; Donaldson MC; Hunink MG
Radiology; 2002 Jan; 222(1):25-36. PubMed ID: 11756701
[TBL] [Abstract][Full Text] [Related]
7. Design of the multicenter standardized supervised exercise training intervention for the claudication: exercise vs endoluminal revascularization (CLEVER) study.
Bronas UG; Hirsch AT; Murphy T; Badenhop D; Collins TC; Ehrman JK; Ershow AG; Lewis B; Treat-Jacobson DJ; Walsh ME; Oldenburg N; Regensteiner JG;
Vasc Med; 2009 Nov; 14(4):313-21. PubMed ID: 19808716
[TBL] [Abstract][Full Text] [Related]
8. A non-randomised controlled trial of the clinical and cost effectiveness of a Supervised Exercise Programme for claudication.
Lee HL; Mehta T; Ray B; Heng MS; McCollum PT; Chetter IC
Eur J Vasc Endovasc Surg; 2007 Feb; 33(2):202-7. PubMed ID: 17142065
[TBL] [Abstract][Full Text] [Related]
9. Impact of chronic kidney disease on outcomes of superficial femoral artery endoluminal interventions.
Bakken AM; Protack CD; Saad WE; Hart JP; Rhodes JM; Waldman DL; Davies MG
Ann Vasc Surg; 2009; 23(5):560-8. PubMed ID: 19128934
[TBL] [Abstract][Full Text] [Related]
10. Cost determinants of percutaneous and surgical interventions for treatment of intermittent claudication from the perspective of the hospital.
Janne d'Othée B; Morris MF; Powell RJ; Bettmann MA
Cardiovasc Intervent Radiol; 2008; 31(1):56-65. PubMed ID: 17973158
[TBL] [Abstract][Full Text] [Related]
11. Outcomes after endovascular intervention for chronic critical limb ischemia.
O'Brien-Irr MS; Dosluoglu HH; Harris LM; Dryjski ML
J Vasc Surg; 2011 Jun; 53(6):1575-81. PubMed ID: 21514777
[TBL] [Abstract][Full Text] [Related]
12. Sirolimus for below the knee lesions: mid-term results of SiroBTK study.
Commeau P; Barragan P; Roquebert PO
Catheter Cardiovasc Interv; 2006 Nov; 68(5):793-8. PubMed ID: 17039538
[TBL] [Abstract][Full Text] [Related]
13. Outcome of the use of stent grafts to salvage failed arteriovenous accesses.
Webb KM; Cull DL; Carsten CG; Johnson BL; Taylor SM
Ann Vasc Surg; 2010 Jan; 24(1):34-8. PubMed ID: 19765947
[TBL] [Abstract][Full Text] [Related]
14. Clinical outcomes of mesenteric artery stenting versus surgical revascularization in chronic mesenteric ischemia.
Kougias P; Huynh TT; Lin PH
Int Angiol; 2009 Apr; 28(2):132-7. PubMed ID: 19367243
[TBL] [Abstract][Full Text] [Related]
15. Absence of Long-Term Benefit of Revascularization in Patients With Intermittent Claudication: Five-Year Results From the IRONIC Randomized Controlled Trial.
Djerf H; Millinger J; Falkenberg M; Jivegård L; Svensson M; Nordanstig J
Circ Cardiovasc Interv; 2020 Jan; 13(1):e008450. PubMed ID: 31937137
[TBL] [Abstract][Full Text] [Related]
16. Cost effectiveness of paclitaxel-eluting stents for patients undergoing percutaneous coronary revascularization: results from the TAXUS-IV Trial.
Bakhai A; Stone GW; Mahoney E; Lavelle TA; Shi C; Berezin RH; Lahue BJ; Clark MA; Lacey MJ; Russell ME; Ellis SG; Hermiller JB; Cox DA; Cohen DJ;
J Am Coll Cardiol; 2006 Jul; 48(2):253-61. PubMed ID: 16843171
[TBL] [Abstract][Full Text] [Related]
17. The Claudication: Exercise Vs. Endoluminal Revascularization (CLEVER) study: rationale and methods.
Murphy TP; Hirsch AT; Ricotta JJ; Cutlip DE; Mohler E; Regensteiner JG; Comerota AJ; Cohen DJ;
J Vasc Surg; 2008 Jun; 47(6):1356-63. PubMed ID: 18440181
[TBL] [Abstract][Full Text] [Related]
18. Intermittent claudication: clinical effectiveness of endovascular revascularization versus supervised hospital-based exercise training--randomized controlled trial.
Spronk S; Bosch JL; den Hoed PT; Veen HF; Pattynama PM; Hunink MG
Radiology; 2009 Feb; 250(2):586-95. PubMed ID: 19188327
[TBL] [Abstract][Full Text] [Related]
19. Lower extremity angioplasty: impact of practitioner specialty and volume on practice patterns and healthcare resource utilization.
Vogel TR; Dombrovskiy VY; Carson JL; Haser PB; Graham AM
J Vasc Surg; 2009 Dec; 50(6):1320-4; discussion 1324-5. PubMed ID: 19837538
[TBL] [Abstract][Full Text] [Related]
20. Do current outcomes justify more liberal use of revascularization for vasculogenic claudication? A single center experience of 1,000 consecutively treated limbs.
Taylor SM; Kalbaugh CA; Healy MG; Cass AL; Gray BH; Langan EM; Cull DL; Carsten CG; York JW; Snyder BA; Youkey JR
J Am Coll Surg; 2008 May; 206(5):1053-62; discussion 1062-4. PubMed ID: 18471755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
